Following amputation, most amputees still report feeling the missing limb and often describe these feelings as excruciatingly painful. Phantom limb sensations (PLS) are useful while controlling a prosthesis; however, phantom limb pain (PLP) is a debilitating condition that drastically hinders quality of life. Although such experiences have been reported since the early 16th century, the etiology remains unknown. Debate continues regarding the roles of the central and peripheral nervous systems. Currently, the most posited mechanistic theories rely on neuronal network reorganization; however, greater consideration should be given to the role of the dorsal root ganglion within the peripheral nervous system. This Review provides an overview of the proposed mechanistic theories as well as an overview of various treatments for PLP.

from a NATO lecture series on the topic of mTBI, demonstrating utility of having patients present their experiences to a medical audience, linking practical clinical care to policy approaches.

There are over two million individuals living with amputations in the United States. Almost all will experience the feeling of the amputated limb as still present, termed phantom limb sensation (PLS). Over 85% will also experience excruciatingly painful sensations known as phantom limb pain (PLP). Additionally some amputees also experience a sensation of the phantom limb in which the limb is immobile or stuck in a normal or abnormal anatomical position, termed frozen phantom sensations. When an amputee experiences a frozen limb they report that they are unable to move the limb, and sometimes report sensations of cramping and pain along with this immobility, fortunately not all frozen limbs are painful. Such sensations have previously been attributed to proprioceptive memories of the limb prior to amputation or a mismatch between visual feedback and proprioceptive feedback resulting from the initiation of a movement. Unfortunately there has been a dearth of research specifically focused on the frozen PLS. We conducted a survey to better elucidate and understand the characteristics and experiences of frozen PLSs. Results from the survey provided descriptions of a variety of frozen limb experiences, such as position and feelings experienced, combined with other phantom pain sensations, casting doubt on previous theories regarding frozen limbs. Further research needs to be focused on the etiology of phantom sensations and pain, which may not necessarily be maintained by the same processes, in order to understand better ways to treat PLP, increase mobility, and enhance amputees quality of life.

Doxorubicin (DOX), a category D pregnancy drug, is a chemotherapeutic agent that has been shown in animal studies to induce fetal toxicity, including renal abnormalities. Upregulation of the transient receptor potential cation (TRPC) 6 channel is involved in DOX-induced podocyte apoptosis. We have previously reported that TRPC6-mediated Ca2+ signaling promotes neonatal glomerular mesangial cell (GMC) death. However, it is unknown whether DOX alters mesangial TRPC expression or viability in the fetus. In this study, cell growth was tracked in control and DOX-treated primary GMCs derived from fetal pigs. Live-cell imaging demonstrated that exposure to DOX inhibited the proliferation of fetal pig GMCs and induced cell death. DOX did not alter the TRPC3 expression levels. By contrast, TRPC6 protein expression in the cells was markedly reduced by DOX. DOX treatment also attenuated the TRPC6-mediated intracellular Ca2+ elevation. DOX stimulated mitochondrial reactive oxygen species (mtROS) generation and mitophagy by the GMCs. The DOX-induced mtROS generation and apoptosis were reversed by the mitochondria-targeted antioxidant mitoquinone. These data suggest that DOX-induced fetal pig GMC apoptosis is independent of TRPC6 channel upregulation but requires mtROS production. The mtROS-dependent GMC death may contribute to DOX-induced fetal nephrotoxicity when administered prenatally.

No abstract